Beijing Liangyuan Pharmaceutical Research

Beijing Liangyuan Pharmaceutical Research is a specialized pharmaceutical research and development organization based in Beijing, China, focusing on high-end generic drug development and innovative small molecule discovery. The company operates as a comprehensive Contract Research Organization (CRO), providing services that encompass chemical synthesis, formulation research, and clinical bioequivalence studies. Liangyuan is a recognized leader in the Chinese pharmaceutical industry's consistency evaluation initiative, ensuring that generic medicines meet stringent quality and efficacy standards. Its portfolio primarily targets therapeutic areas such as cardiovascular health, metabolic disorders, and oncology. By integrating advanced formulation technology with rigorous regulatory compliance, Liangyuan Pharmaceutical supports the growth of both domestic and international pharmaceutical partners.